Brief: CareDx Q3 Adjusted EPS USD 0.28 Vs. IBES Estimate USD 0.14
04/11/2025 21:05
Nov 04 (Reuters) - CareDx Q3 adjusted EBITDA USD 15.3 million vs. IBES estimate USD 7.93 million. Q3 EPS USD 0.03 Q3 net income USD 1.7 million Q3 adjusted net income USD 14.9 million vs. IBES estimate USD 7.48 million Q3 revenue USD 100 million vs. IBES estimate USD 95.3 million
Recent news on CareDx
See all newsBrief: Caredx Announces New Koar Data Linking Elevated Allosure® Kidney To Nearly 3-Fold Higher Risk Of Adverse Graft Outcomes In Patients With Borderline Rejection Or Tcmr At Asn Kidney Week 2026
US RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
CareDx Inc reports results for the quarter ended June 30 - Earnings Summary
CareDx Q2 revenue beats estimates; outlook lifted
Brief: CareDx Q2 Adjusted EPS USD 0.37 Vs. IBES Estimate USD 0.23